Mode
Text Size
Log in / Sign up

Can T cell epitope vaccines help control dengue virus infection?

moderate confidence  ·  Last reviewed May 22, 2026

Dengue virus causes fever and can lead to severe illness, especially in people infected for the second time. Current vaccines carry risks, but new approaches using T cell epitopes aim to create safer protection. Research suggests these vaccines could help control the infection by stimulating the immune system to fight the virus directly.

What the research says

T cell epitopes are specific parts of the virus that trigger the body's cellular immune response. When the immune system sees these parts, it produces cytokines and activates cells that directly fight the virus. Studies indicate that inducing this type of immunity can help control dengue infection and may lower the risk of antibody-dependent enhancement, a process that makes secondary infections worse 3.

The protective role of T cells is well-established in fighting viral infections. CD8 T cells can kill infected cells, while CD4 T cells help other immune cells work better. To make a vaccine, scientists must identify specific T cell epitopes from the virus to ensure the vaccine triggers the right immune response. This allows researchers to study how the immune system reacts to the virus 4.

Because existing vaccines can sometimes cause severe disease in people without prior infection, new strategies are needed. T cell epitope-based vaccines are designed to complement current methods and offer new ideas for prevention. Computational tools are also being used to design multi-epitope vaccines that target all four dengue virus serotypes, aiming for safer and more effective protection 6.

What to ask your doctor

  • What are the current risks and benefits of T cell epitope vaccines compared to existing dengue vaccines?
  • How do T cell epitope vaccines aim to reduce the risk of severe dengue in people who have been infected before?
  • Are there clinical trials for T cell epitope vaccines that I could participate in or monitor?
  • What specific dengue virus serotypes do these new vaccine designs target?

This question is drawn from common patient questions about Infectious Disease and answered using cited medical research. We do not provide individualized advice.